Aimz Investment Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Aimz Investment Advisors, LLC

$265 Million
Q1 2024

A detailed history of Aimz Investment Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Aimz Investment Advisors, LLC holds 10,169 shares of REGN stock, worth $10.7 Million. This represents 3.7% of its overall portfolio holdings.

Number of Shares

10,169

Previous 10,439 2.59%

Holding current value

$10.7 Million

Previous $9.17 Million 6.75%

% of portfolio

3.7%

Previous 3.75%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$902.69 - $993.35 $243,726 - $268,204	-270 Reduced 2.59%	10,169 $9.79 Million
Q4 2023 Jan 26, 2024	SELL	$775.18 - $881.7 $132,555 - $150,770	-171 Reduced 1.61%	10,439 $9.17 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $44,316 - $54,039	-64 Reduced 0.6%	10,610 $8.73 Million
Q2 2023 Aug 08, 2023	SELL	$700.03 - $830.35 $14,000 - $16,607	-20 Reduced 0.19%	10,674 $7.67 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $98,671 - $119,910	-145 Reduced 1.34%	10,694 $8.79 Million

Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $158,825 - $172,437	-225 Reduced 2.03%	10,839 $7.82 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $28,698 - $36,216	-50 Reduced 0.45%	11,064 $7.62 Million
Q2 2022 Aug 02, 2022	SELL	$548.35 - $738.84 $27,417 - $36,942	-50 Reduced 0.45%	11,114 $6.57 Million
Q1 2022 May 06, 2022	SELL	$595.12 - $698.43 $154,731 - $181,591	-260 Reduced 2.28%	11,164 $7.8 Million
Q4 2021 Feb 09, 2022	BUY	$543.48 - $670.97 $67,935 - $83,871	125 Added 1.11%	11,424 $7.21 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $80,364 - $95,334	-140 Reduced 1.22%	11,299 $6.84 Million
Q1 2021 Apr 28, 2021	BUY	$446.73 - $548.2 $22,336 - $27,410	50 Added 0.44%	11,439 $5.41 Million
Q4 2020 Feb 08, 2021	SELL	$478.3 - $607.98 $47,830 - $60,798	-100 Reduced 0.87%	11,389 $5.5 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $92,607 - $111,895	-170 Reduced 1.46%	11,489 $6.43 Million
Q2 2020 Aug 07, 2020	SELL	$493.32 - $643.92 $27,132 - $35,415	-55 Reduced 0.47%	11,659 $7.27 Million
Q4 2019 Feb 13, 2020	SELL	$274.13 - $376.51 $30,154 - $41,416	-110 Reduced 0.93%	11,714 $4.4 Million
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $627,317 - $730,386	2,294 Added 24.07%	11,824 $3.28 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $33,582 - $40,304	-100 Reduced 1.04%	9,530 $3.56 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $19,922 - $24,149	70 Added 0.73%	9,630 $3.32 Million
Q1 2018 May 01, 2018	BUY	$315.82 - $393.78 $3.02 Million - $3.76 Million	9,560 New	9,560 $3.29 Million

Others Institutions Holding REGN

# of Institutions

1,424

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aimz Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aimz Investment Advisors, LLC with notifications on news.

Account

Aimz Investment Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History